Objective: The combination of anorganic bovine bone (ABB) with platelet-rich plasma (PRP) has been widely used in bone regeneration procedures although its benefits are still unclear. The purpose of this study was to evaluate whether or not PRP improves the efficacy of ABB in sinus floor augmentation. In addition, we have investigated the effect of residual bone height and tobacco on implant survival in sinus augmentation procedures. Pateint and Methods: Eighty-seven patients recruited for this study underwent 144 sinus floor augmentation procedures using ABB alone or ABB plus PRP (ABB1PRP) in a randomized clinical trial. A total of 286 implants were placed in the augmented bone, and their evolution was followed up for a period of 24 months. In order to investigate on a histological level and any adjunctive effects, we performed an ancillary study in five edentulous patients with a symmetrical severely resorbed maxilla. In these patients, a bilateral sinus augmentation was randomly performed using ABB or ABB1PRP in a split-mouth design, and after 6 months, bone biopsies were taken from the implant sites for histological and histomorphometric analysis. Results: Overall, 96.2% of ABB and 98.6% of ABB1PRP implant success were obtained during the monitoring period and differences were not found between sites grafted with and without PRP in the 87 patients studied. Densitometry assessments and graft resorption were similar in both experimental groups. However, the histological and histomorphometrical analysis in the five edentulous patients revealed that bone augmentation was significantly higher in sites treated with ABB1PRP (p40.05). Another outcome from our study is that the lack of initial bone support (p40.05) and smoking (p 5 0.05) appeared to have a negative effect on the treatment success, which was accentuated when both circumstances coincided. Conclusions: PRP is not a determining factor for implant survival in sinus lifting procedures. However, this study revealed that PRP can improve the osteoconductive properties of ABB by increasing the volume of new bone formed. Moreover, in sinus augmentation procedures the implant's survival rate appears to be more influenced by the residual bone height or by tobacco than by the type of bone graft.
resorption, two factors that render the initial stability of Q2 dental implants difficult (Mish 1990 , McCarthy et al. 2003 . Besides, the volume of bone in this area is usually limited by the maxillary sinus pneumatization, hindering implant placement Q3 (Brånemark et al. 1984 , Blomqvist et al. 1996 .
The maxillary sinus-lift surgical technique increases the bone height in the posterior area, and enables the placement of implant-supported prostheses (Tatum 1986 ). This procedure involves the detachment of Shneider's membrane from the maxillary sinus floor, creating a space that is filled with a grafting material to promote a vertical bone augmentation into the maxillary sinus cavity.
Different grafting materials have been used to fill the space created between the superiorly repositioned sinus membrane and the floor of the maxillary sinus. Early studies advocated the use of autogenous bone in the augmented space (Boyne & James 1980) . However, its availability is restricted by the limited amount of intra-oral grafts, the morbidity associated with the second surgery at the donor site and the high cost for bone harvesting from extra-oral sites. Therefore, alternative graft materials have been developed, including demineralized (human) bone matrix (Groeneveld et al. 1999 ) anorganic bovine bone Q4 (ABB) (Valentini & Abensur 2003) , tricalcium phosphate (Zijderveld et al. 2005) or bioactive glass particles (Tadjoedin et al. 2000) .
Bio-Oss s (Geistlich Biomaterials Q5
) is a biocompatible and osteoconductive (Benezra et al. 2002 Q6 ) ABB that provides an ideal scaffold for new bone formation Q7 (Hämerle et al. 1998 , Piattelli et al. 1999 . It has Q8 been extensively used in maxillary sinus floor augmentation (Valentini & Abensur 2003 , Wallace et al. 2005 with high clinical success rates (Carmagnola et al. 2003) . However, the lack of osteo-inductive properties encouraged researchers to find ways of improving its performance in vivo, and the addition of platelet-rich plasma (PRP) has been assayed. PRP is an autologous fibrin adhesive with a high platelet concentration easily obtained from whole blood by centrifugation Q9 (Antonaides 1981 , Marx et al. 1998 , Anitua 1999 . Furthermore, PRP has a high concentration of angiogenic and mitogenic growth factors implicated in bone healing, such as transforming growth factor (TGF) (Wikesjö et al. 1998 ) Q10
, platelet-derived growth factor (PDGF) and insulin-like growth factor (Giannobile et al. 1996) , and has been used in sinus floor elevation recently Q11 (Philippart et al. 2005 , Consolo et al. 2007 , Galindo-Moreno et al. 2007 ). Nevertheless Q12 , preliminary case reports using PRP as an adjuvant in bone regeneration procedures have been controversial Q13 (Anitua 1999 , Roldán et al. 2004 , Wiltfang et al. 2004 , Kassolis & Reynolds 2005 , Philippart et al. 2005 , Klongnoi et al. 2006a , b, Consolo et al. 2007 , Galindo-Moreno et al. 2007 
Patient and Methods

Patients
Inter-patient randomized-controlled clinical trial
Patients were enrolled in the study on the basis of having insufficient bone height (o7 mm) in the posterior maxilla.
In these patients, sinus floor augmentation was planned to allow rehabilitation with fixed implant-supported prosthesis. Smokers were included in the study, while patients with severe systemic disease [American Society of Anaesthesiology (ASA) III or IV] and a previous history of chronic sinusitis were excluded. Informed written consent to participate in this study was obtained from all patients, in particular explaining the objectives and protocol of the study, and possible side effects. Before commencing this study, approval was obtained from the ethical committee for clinical trials of the ''Hospital San Carlos'' (Madrid, Spain), to carry out a pilot clinical study in the dental clinic ''Clinica Dental Alcala'' (Madrid, Spain).
During the study period (2003) (2004) (2005) (2006) (2007) (2008) , 209 patients attended ''Clinica Dental Alcala'' demanding implant treatment. Among these patients, 87 were recruited for this randomized-controlled clinical trial on the basis of having o7 mm of residual ridge in the posterior maxilla. Patients with residual bone height o4 mm received a two-stage approach while patients with residual bone height ! 4 mm received a one-stage approach (Zinner & Small 1996 , Jensen et al. 1998 . A total of 144 sinus floor augmentations were performed (Fig. 1) . There was heterogeneity in the systemic diseases present in some of the selected patients, such as diabetes, heart failure and osteoporosis; however, none of these conditions are known to jeopardize the implant's success (Mombelli & Cionca 2006) . On the other hand, there are several authors who associate smoking with dental implant Q17 failure (Bain & Moy Q16 1993 , De Bruyn & Collaert 1994 , Gorman et al. 1994 , Wallace 2000 , Chuang et al. 2002 , which led us to consider Q18 this variable and to evaluate its effects on implant survival in sinus augmentation procedures. Patients who reported smoking 4ten cigarettes/day were defined as smokers (Tonetti et al. 1995) , while patients who reported smoking only occasionally were not considered to be smokers.
Split-mouth randomized-controlled clinical trial
In addition to the above-mentioned criteria, the inclusion criteria for the splitmouth study were patients with bilateral loss of teeth in the maxillary premolar and molar areas, and Cadwood classification V Q19 or VI (Cawood & Howell 1991) that required a bilateral, twostage, sinus floor-lifting procedure (first stage, bone grafting; second stage, placement of implants) (Boyne & James 1980) . Radiography (orthopantomography) and computed tomography (CT) were performed 6 months post-operatively on surgical sites, before and after treatment, and the bone density was quantified in both PRP1ABB and ABB groups using SIMPlant 7 (Columbia Scientific, Columbia, MD, USA) software. Six selected zones in each maxillary sinus were chosen for a standardized evaluation (Rao & Alfidi 1981) . All five patients were edentulous for 7-10 years in the maxilla, which had insufficient retention for their upper denture with a residual alveolar ridge between 1 and 3 mm diagnosed by CT (see Fig. 2 ).
Randomization
The allocation of participants to intervention groups in a truly unpredictable, randomized sequence was performed by a computerized random number generated using GraphPadQuickCalc software (GraphPad Software Inc., La Joya, CA, USA), including the concealment of the allocation schedule until the assignment was made. Subject numbers were assigned at the baseline examination in consecutive order by the principal investigator. The sample size used has been usual in pervious studies for this type of clinical evaluation. Patients included in the inter-patient clinical trial were allocated by a blinded assistant into two groups: the first was to be treated with ABB alone, and the second with ABB1PRP. On the other hand, each of the patients included in the split-mouth study was treated with ABB alone in the maxilla of one side and with ABB1PRP in the contralateral one. The graft materials were randomly allocated for either side in each patient.
Blinding
The surgeon was blinded to the graft material applied to each patient before graft implantation. An assistant handled the PRP-ABB or the ABB group after the surgeon had already accessed the sinus and elevated the membrane. The histologist was blinded to the samples' groups throughout the histomorphometrical analysis.
PRP
PRP was prepared according to Anitua's method 15 (Anitua 1999) . Blood was collected from all patients 30 min before starting the surgery to ensure that the blinding of the surgeon was maintained. In the ABB1PRP group, between 10 and 20 cm 3 of blood was withdrawn via venous aspiration into 4.5 cm 3 test tubes and mixed with a 3.8% sodium citrate solution at a 5/1 (v/v) ratio, achieving anticoagulation through calcium binding. The blood was then centrifuged using a Bti s PRGF System II centrifuge (Bti Biotechnology Institute S.L., Vitoria, Spain) into three basic components: red blood cells (RBCs), PRP and plateletpoor plasma (PPP). Because of the different densities of the components, the RBC layer forms at the bottom of the tube, the PRP layer in the middle and the PPP layer at the top. A pipette (Gilson Inc., Middleton, WI, USA) was used to separate the layers, from the less dense to the denser. Therefore, PPP was separated first (about 2.25 cm ). Flow cytometry (ADVIA 120, Hematology system, Bayer, Leverkusen, Germany) was used for platelet counting.
Platelet counts were 2.97 AE 0.7-fold over peripheral blood, confirming that the PRP preparation technique used in this study produced a source of highly concentrated platelets. The average peripheral blood platelet count was 275.000 AE 58.000/ml. Before its surgical application, PRP (0.2 ml) was activated with a 30% CaCl 2 solution, and a PRP gel was obtained and mixed with ABB ($ 1.5 g).
Surgical protocol
Because of the insufficient bone height for implant stabilization, in all cases, the sinus floor augmentation was prepared following the method described by Boyne & James (1980) and Tatum (1986) . The decision to place simultaneous or delayed implants depended on whether or not the residual crest had enough bone height to permit primary implant stability (Zinner & Small 1996 , Jensen et al. 1998 .
The osteotomy of the lateral wall of the maxilla was performed under local anaesthesia, and the entire buccal plate was removed before the elevation of the sinus membrane and the implantation of the assigned graft material. No membranes were used to cover the lateral wall defect after the bone substitute was placed. In the two-stage sinus augmentation procedure, a healing time of 6 months was allowed before implant placement (Osseotite, Biomet 3i Inc., Palmbeach, FL, USA).
Post-operatively, antibiotics, anti-inflammatory and antiseptics were prescribed, and sutures were removed 1 week after surgery. Patients were instructed not to wear their prosthesis for 2-3 weeks after surgery. For the next 4 months, the existing upper prosthesis was adapted to the maxilla for aesthetics and relined periodically with a soft tissue conditioner. All patients were required to follow a soft diet and no mastication was permitted.
Histological and histomorphometric procedures
The histological and histomorphometic analysis was performed in the five patients recruited for the split-mouth randomized clinical trial. In these patients, bone biopsies were obtained from both treated sites. After a healing period of 6 months, these patients were called for implant placement and biopsies were retrieved from dental-implant sites using a trephine burr (Ø 5 3.0 mm Â 10.0 mm in length) (see Fig. 3 ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 Subsequently, the biopsies were fixed in 10% formaldehyde (pH 7.4) and stored at 41C. After dehydration in ascending series of alcohol (60-100%), biopsies were embedded in 2-hydroxy-ethylmethacrylate (Technovit, Leica Microsystems GMBH, Wetzlar, Germany), then photopolymerized for 6 h with ultraviolet light, 2 h with white light and 6 h with blue light into ready-tocut sample blocks.
A saw microtome Exakt s (Leica Microsystems GmbH) was used to cut 200-mm-thick coronal sections from the cylinders. Thereafter, the sections were ground to a thickness of 40-50 mm by means of a grinder Exakt s (EXAKT, Norderstedt, Germany) to achieve better histological visualization without risking the loss of the samples. Afterwards, surface staining was performed with basic fuchsine and methylene blue (Donath & Breuner 1982) . The histological evaluation of bone neoformation was carried out by means of optical microscopy. The histomorphometric analysis was performed using light micrographs (at magnification Â 6) of the biopsy slices, which were captured with a digital camera and analysed with the histomorphometric software MIP-4 (Digital Image System, Barcelona, Spain). The sections were analysed by a single examiner blinded to the bone graft material and the following measurements were taken from each sample: newly formed bone volume (NB), soft tissue volume (ST) and residual graft volume (RG). The measurements were expressed as percentages of the total sample volume. The distribution of the patients' systemic conditions (diabetes, smoking, etc.) among clinical treatments' groups was assessed using the w 2 test, in order to evaluate comparability between groups. Moreover, two-way analysis of variance tests, in the univariate analysis, were used to find any association between patients' (i) systemic conditions and (ii) treatment on the one hand and (i) implant survival and (ii) patient treatment success on the other. A multiple stepwise logistic regression analysis was performed to assess the joint contribution of the smoking behaviour and residual bone height to implant survival. Histomorphometric measurements of the biopsies taken from the grafted sites were compared within each patient using a t-test for paired samples. For all univariate analyses, a p40.05 was chosen. A statistical software package (SPSS 17.0, SPSS, Chicago, IL, USA) was used for the statistical analysis. Table 1 ). The presence of systemic disorders was registered among the study groups. The distribution of systemic disorders was balanced among the different treatment groups (Fig. 4) . Q30 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 Among the study groups, 144 sinus floor augmentations were performed to receive a total of 286 implants (10-13 mm long). The implantation was deferred in 57 sinuses and immediate in 87. Table 2 summarizes the results obtained.
Healing was uneventful in all patients because none of them complained of significant pain and no signs or symptoms of infection were reported. All sinus-augmented sites allowed the installation of one to three rough-surfaced implants (Osseotite, Biomet 3i Inc.) with diameters between 3.75-5 and 10-13.0 mm long. Radiological images show that all implants displayed full-bony integration (see Fig. 5 ). Six months after their insertion, the implants were uncovered and the patients were rehabilitated with fixed bridge prostheses. After the 24-month follow-up period, 98.6% of the patients treated with PRP1ABB and 96.2% of those treated with ABB presented implant survival.
This table shows that therapeutic groups were balanced on the basis of smoking, gender, type of augmentation and residual bone height to confirm that randomization worked.
Surgical complications
Sinus membrane dehiscence was observed in five cases (5.74%) and all of them were small perforations (45 mm). In the three cases observed in the PRP1ABB group, the dehiscence was sealed using PRP alone whereas a collagen membrane was used in the ABB group (Fig. 6) . One adverse result in outcome survival was associated with sinus membrane dehiscence in a second-stage augmentation procedure grafted with ABB.
Type of bone graft
The adhesive capacity of fibrin in PRP1ABB facilitates the handling of the graft material as compared with the particles of ABB alone, making the filling of the sinus cavity easier (see Fig. 7 ).
Survival of grafts
Graft survival at the secondary surgery was sufficient to allow implant placement in all the patients included in the study. However, we found that in five cases partial loss of bone graft occurred probably because membrane coverage was not used (Fig. 8) . . The adhesive capacity of platelet-rich plasma improves the handling of anorganic bovine bone and facilitates the filling of the sinus cavity. Fig. 8 . Absence of membrane coverage of the buccal plate of the maxilla after filling the cavity resulted in a residual space filled with connective tissue (white arrows) and partial loss of bone graft ( n ) in some patients. However, we did not observe an excessive graft loss that may compromise implant placement at second-stage surgery in any patient . 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 Survival rates Implant survival is defined as the implant remaining in situ during the entire observation period. In this study, out of over 286 implants placed, 279 remained in situ during the entire observation period, being tested independently for absence of mobility, and seven failed, which yielded 97.5% implant survival. We found differences between the one-and two-stage surgery groups, indicating that the residual height could affect the survival rate. Furthermore, six implants were lost at sites with residual bone height o4 mm, while only one was lost at sites with residual bone height between 4 and 7 mm. This result indicates that the amount of residual bone height significantly influenced the implant survival after sinus augmentation (p40.05); however, the bone graft type seemed to have no effect on implant survival. Implant failure was higher before prosthetic loading, and in smokers (see Table 3 ). Indeed, five out of the seven failed implants occurred in four smoking patients (p40.05). The details of the implant's failure in the inter-patient study are given in Table 4 .
Treatment success rate was defined as the rate of patients that presented complications during the observation period. According to this definition, 92.8% of the patients' treatments were successful. Moreover, treatments' success seemed to be higher in patients with more residual bone height (p 5 0.05), and in non-smokers (p40.05).
Moreover, a o4 mm residual bone height and smoking had a combined negative effect on the treatment success rate, although these differences did not reach statistical significance in the univariate and multivariate analyses (see Table 5 ).
Both the patient-based and the implant-based statistical analysis of the treatment groups agreed on the negative effect that both smoking and reduced residual bone height had on the implant survival and treatment success. Although there was no significant interaction between the two effects, the data suggested that the negative effect on the treatment success was accentuated when both circumstances coincided.
Split-mouth-controlled clinical trial
The five patients included in the splitmouth-controlled clinical trial received 10 sinus floor augmentations with a total of 26 implants. A summary of the results obtained from these patients is presented in Table 6 .
After 6 months, CT showed no significant differences between ABB-and PRP1ABB-treated sites (see Fig. 9 ). In both cases, the augmented bone pre- 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 sented adequate volume for implant placement, and both sites showed a similar radiographic aspect. Similarly, densitometric assessment showed no significant differences between both treatment modalities (see Fig. 10 ). The height of the augmented bone was similar in both groups: 10.4 AE 0.7 and 9.4 AE 0.7 mm in PRP1ABB and ABB, respectively.
Upon histological observation, all biopsies revealed the presence of trabecular bone and remaining ABB granules within the treated maxillary sinuses (see Fig. 11 ). Differences between native pre-existing bone and newly formed bone were clearly observed because of the presence of ABB particles in the whole augmented area. On the surfaces of ABB particles, newly formed bone and connective tissue were present. The growth of bone took place mainly through the guidance of ABB particles from the pre-existing bone surface of the sinus floor along the augmented area, and bridges of woven bone between the grafted particles could be observed, connecting them into a mass of mineralized tissue (see Fig. 12 ). We also observed newly formed bone even in the most apical part of the samples. Bone formation around the grafted bone particles (ABB) was seen in both the PRP and the non-PRP group. Furthermore, as shown in Fig. 13 , the resorption of ABB particles is low.
Histomorphometric analysis revealed that the area occupied by newly formed bone was higher in the sites treated with PRP, while the average areas occupied by ABB particles were almost the same in the two groups (see Fig. 14) .
Discussion
Although sinus lifting is a reliable technique for vertical bone augmentation in the posterior maxilla, implant loss is still registered as often as in 17% of the patients with less than 6 mm residual bone Q20
height (Tonetti & Hämmerle 2008) . For this reason, bioactive agents are being tested in order to improve the clinical outcome of these procedures (Palmer et al. 2008) .
Platelets are a natural source of growth factors with beneficial effects on tissue healing (Lynch et al. 1991 , Giannobile et al. 1996 , Wikesjö et al. 1998 , Anitua et al. 2004 ; however, the Q21 use of PRP in bone regeneration in humans is a moot question (Anitua 1999 , Roldán et al. 2004 , Wiltfang et al. 2004 , Kassolis & Reynolds 2005 , Philippart et al. 2005 , Klongnoi et al. 2006a , b, Consolo et al. 2007 , GalindoMoreno et al. 2007 ). Recent systematic reviews of randomized-controlled clinical trials combining PRP with grafting materials still show conflicting and inconclusive results (Palmer et al. 2008) . The controversy extends to animal studies because in some of them, significant benefits have been reported Fig. 9 . Computed tomography of the same patient before (a) and 6 months after (b) surgery. The right sinus was grafted with PRP1ABB, and the left sinus was grafted with ABB alone. ABB, anorganic bovine bone; PRP, platelet-rich plasma. Fig. 10 . Densitometry of maxillary sinuses before treatment, and 6 months after initial intervention in the patients included for the split-mouth clinical trial. Table  7 , showing residual bone (RB) and two squares delimiting coronal (dark square) and apical (white square) sites of the sample, where new bone formation appears between ABB particles in both groups: the one treated with ABB alone (a) and the one treated with PRP1ABB (b). (Original magnification Â 2.5.) ABB, anorganic bovine bone; PRP, platelet-rich plasma. Fig. 12 . Image of patient 3 of Table 7 . Bone formation took place in the coronal part of the biopsy in both groups (a) PRP1ABB and (b) ABB alone. The presence of new bone (NB) surrounding ABB particles (RG, residual graft) and creating bridges between ABB particles can be observed in both groups. (Original magnification Â 20.) ABB, anorganic bovine bone; PRP, platelet-rich plasma.
Q29
Effect of platelet-rich plasma on sinus lifting Q1with the use of PRP mixed with bone substitutes in sinus Q22 lift procedures (Kassolis et al. 2000 , Rodriguez et al. 2003 , Mazor et al. 2004 , Kassolis & Reynolds 2005 , whereas other studies have not Q23
shown any beneficial effect (Aghaloo et al. 2002 , Fürst et al. 2003 , Jakse et al. 2003 , Butterfield et al. 2005 , Klongnoi et al. 2006a , b, Roldán et al. 2008 . One possible explanation for the disagreement could be attributed to the different number of centrifugations used for preparing PRP (one or two centrifugations) (Marx et al. 1998 , Anitua 1999 . The main advantage of one centrifugation technique is the minimum leucocyte count and lesser concentration of PDGF and TGF-b in comparison with two centrifugation techniques. The absence of leucocytes is important because neutrophils are a source of matrix metalloproteinases and secrete other proteases, such as elastases that are destructive for growth factors (Anitua et al. 2008) . Moreover, in the two centrifugation techniques, there are different methods for cell separation (Weibrich et al. 2002a (Weibrich et al. , b, 2003a (Weibrich et al. , b, 2004 ) that lead to significant differences in the amounts of cells (platelets and leucocytes) and levels of growth factors in the PRP samples (Weibrich et al. 2003a, b) .
The concentration of platelets seems to play an important role in the regenerative process. Thus, PRP with an intermediate concentration of platelets (two to sixfold from peripheral blood) have shown beneficial effects, while lower (0.5-1.5-folds) and higher (9-11-folds) concentrations did not demonstrate beneficial effects (Weibrich et al. 2004) . Herein, the centrifugation technique concentrates platelets to 2.9 AE 0.7-fold over peripheral blood, supporting a desirable effect of PRP.
After 6 months of treatment, our results did not show significant differences between densitometric values of the augmented areas between both groups. Raghoebar et al. (2005) obtained similar Q25 results although other studies report higher densitometric values for the PRP sites (Marx et al. 1998 , Consolo et al. 2007 ). However, some clinical studies indicate the ineffectiveness of PRP in sinus augmentation procedures (Danesh-Meyer et al. 2001 , Raghoebar et al. 2005 , Thor et al. 2007 , Schaaf et al. 2008 ). Very few of these studies were proper randomized-controlled clinical trials (Froum et al. 2002 , Raghoebar et al. 2005 , Thor et al. 2005 , Consolo et al. 2007 , Galindo-Moreno et al. 2007 , Plachokova et al. 2008 . Four of these authors used a split-mouth design to evaluate the bone regeneration in sinus floor elevation using PRP as the unique variable. Raghoebar observed, in a split-mouth study on sinus floor elevations, that bone augmentation with autogenous grafts did not increase significantly on adding PRP (41.1% at the non-PRP group and 38.4% at the PRP group) (Raghoebar et al. 2005) . Thor et al. (2007) observed a conspicuous increase in new bone formation obtained by combining PRP with an autogenous bone during early healing stages (3 months). Moreover, Consolo et al. (2007) suggest certain regenerative potential of PRP when used with an autologous bone but no statistical differences were observed between sites treated or not treated with PRP.
Hence, these results confirm the absence of consensus regarding the usefulness of combining autogenous bone with PRP; the same conflicting results appear when PRP is Q24 added to ABB. For instance, Froum et al. (2002) did not observe any benefit from combining PRP with ABB in three bilateral human sinus floor elevation procedures. Galindo-Moreno et al. (2007) using a composite graft of cortical autogenous bone, bovine bone and PRP in sinus floor elevations in humans, observed 34 AE 6% new bone formation and indicated its use as a successful bone graft mixture for sinus augmentation, although the absence of a control group in this study prevents an objective evaluation of the positive effect of PRP.
In our study, the clinical outcome of bone regeneration procedures and the dental implant replacement was not influenced by the addition of PRP to the bone substitute materials. The histomorphometric analysis revealed that the sinuses grafted with ABB alone had approximately the same percentage of augmented bone volume as that reported in similar studies (Tadjoedin and colleagues) . We observed a percentage of new bone formation of 21.3 AE 4.5% while Tadjoedin et al. (2003) reported 22.9 AE 2.5% for the same conditions. However, the sinuses grafted with ABB1PRP had significantly higher amounts of bone volume. Interestingly, the amount of bone volume Q26
obtained by combining ABB with PRP (31 AE 5%) was similar to that reported by other authors for composite grafts combining autogenous bone with ABB in a 1:1 ratio (30.4 AE 2.8%) Q27 (Tadjoedin et al. 2003 , GalindoMoreno et al. 2007 ).
The increased bone regeneration rates observed with PRP were attributed to the growth factor released from platelets, as well as the fibrin network present in PRP that is believed to enhance Table 7 . Bone formation occurred in the apical part of the biopsy in both groups (a) PRP1ABB and (b) ABB alone. Although new bone formation (NB) was observed in both groups, even in the most apical part of the biopsies, more new bone appears in the PRP1ABB group. We also observed a decrease in the number of bone bridges between ABB particles (RG, residual graft) compared with the coronal part of biopsies in the two groups (original magnification Â 10). ABB, anorganic bovine bone; PRP, platelet-rich plasma. 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63 osteoconduction of the bone substitute material (Marx et al. 1998) . Although some authors suggest that PRP induces higher graft resorption rates in autologous bone grafts (Fennis et al. 2004 , Wiltfang et al. 2004 , in this study, PRP did not show any effect on the resorption of the ABB particles. Moreover, the type of bone graft did not influence either implant survival or treatment success.
There are several reports associating smoking with dental implant failure (Chuang et al. 2002 , Schwartz-Arad et al. 2002 . Tobacco contains several noxious substances, resulting in vasoconstriction and decreased tissue perfusion, which produces pathological ischaemia impairing wound healing. In this study, implant survival and treatment success was significantly lower in smoking patients than in non-smokers, smoking thus being an important risk factor in sinus augmentation procedures. This finding confirms previous reports that associate smoking habits with failure of implants placed in augmented sinuses (Olson et al. 2000 , Kan et al. 2002 , Schwartz-Arad et al. 2002 .
The implant survival in augmented maxillary sinuses observed in this study was significantly higher in patients with higher amounts of residual bone height. This result is in agreement with previous studies (Geurs et al. 2001 ). On the other hand, the prevalence of membrane perforation observed was similar to that reported by other authors (5.74%) (Pjetursson et al. 2008 , Tonetti & Hämmerle 2008 . Furthermore, the lateral wall of the maxilla was not covered with any membrane after graft placement, and this did not affect the final outcome of the treatments.
Conclusions
PRP is not a determining factor for implant survival in sinus lifting procedures. However, this study revealed that PRP could improve the osteoconductive properties of ABB by increasing the volume of new bone formed, and also the handling properties of bone substitute particles. Moreover, in sinus augmentation procedures implant survival rate appears to be more influenced by the residual bone height or by tobacco than by the type of bone graft.
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